SPY772.04+0.09%QQQ745.40+0.12%BTC/USD83,996.21−0.12%DIA517.72+0.04%GLD393.05−0.09%TLT79.38+0.08%
Benzinga

Myriad Genetics Inc (MYGN) Stock Price, Quote, News & History

MYGNNASDAQ
Trade with Public
Trade with Public
$4.17
0.030.72%
At close: Sep 25, 5:00 PM EST
$4.10
-0.07-1.68%
After Hours: 6:53 PM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareOptionsStock Report

Myriad Genetics (MYGN) Stock Price, Quote, News & History | Benzinga

Key Statistics

Open
$4.16
Close
$4.17
Volume / Avg.
1.65M / 2.04M
Day Range
$4.07 - $4.25
52 Wk Range
2.74 - 8.59
Market Cap
$387.24M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
63
Short Interest
10.15%
Days to Cover
4.27

Recent Myriad Genetics, Inc. News

Why RH Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket

RH shares jumped 8.2% premarket after EPS beat estimates despite a revenue miss; Oracle and others gained, while OPTT and ZUMZ fell.
Avi Kapoor

Cango, Nio And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session

U.S. stock futures were lower this morning, with the Dow futures falling around 200 points on Tuesday. Shares of Cango Inc (NYSE:CANG) fell sharply in pre-market trading as the company posted downbeat results for the
Avi Kapoor

Crude Oil Gains 1%; Apple Shares Tumble After Q3 Results

Dow up 0.38%, NASDAQ up 0.25%, S&P 500 up 0.22%. Consumer discretionary shares up 5.6%, materials stocks down 2.7%. Apple beats estimates, shares down 9%.
Avi Kapoor

Apple, Stryker, Coinbase And Other Big Stocks Moving Lower In Friday’s Pre-Market Session

U.S. stock futures rise, Nasdaq 100 up 300 points. Apple Inc shares fall 7.4% despite beating analyst estimates for Q3. Other stocks also dip in pre-market.
Avi Kapoor

Why Amazon Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket

Amazon reported strong Q2 results, beating revenue and earnings estimates. Shares jumped 11.9% in pre-market trading while other stocks also saw gains/losses.
Avi Kapoor

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
7.70M
Investing Cash Flow (TTM)
-21.90M
Financing Cash Flow (TTM)
47.20M
Free Cash Flow (TTM)
-14.20M
Capital Expenditure (TTM)
-21.90M
Net Change in Cash (TTM)
33.00M

Analyst Trends and Forecast

1
May
0
0
0
0
Jul
2
Aug
1
1
Sep
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
1.8
Sell
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$494.16M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
0.48
PB Ratio (TTM)
1.31
Earnings Yield % (TTM)
-28.40%
Earnings Yield % (FWD)
-
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$3.18

Company Debt

Total Debt
$120.70M
LT Debt
$120.70M
LT Debt Issuance (TTM)
$125.00M
LT Debt Repayment (TTM)
-$60.30M
Total Cash
$115.20M
Debt to Equity
0.69
Issuance of Debt (TTM)
$64.70M
Repayment of Debt (TTM)
-$60.30M

Key Statistics

Open
$4.16
Close
$4.17
Volume / Avg.
1.65M / 2.04M
Day Range
$4.07 - $4.25
52 Wk Range
2.74 - 8.59
Market Cap
$387.24M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
63
Short Interest
10.15%
Days to Cover
4.27

About

Sector
Health Care
Industry
Biotechnology
Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

FAQ

Q

How do I buy Myriad Genetics (MYGN) stock?

A

You can purchase shares of Myriad Genetics (NASDAQ:MYGN) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Myriad Genetics (MYGN) competitors?

Q

What is the forecast, or price target, for Myriad Genetics (MYGN) stock?

A

Myriad Genetics has a consensus price target of $11.51.

Q

What is the current price for Myriad Genetics (MYGN)?

A

The stock price for Myriad Genetics (NASDAQ: MYGN) is $4.1 last updated September 25, 2026 at 6:53 PM EDT.

Q

Does Myriad Genetics (MYGN) pay a dividend?

A

There are no upcoming dividends for Myriad Genetics.

Q

When is Myriad Genetics (NASDAQ:MYGN) reporting earnings?

A

Myriad Genetics does not have any upcoming earnings scheduled.

Q

Is Myriad Genetics (MYGN) going to split?

A

There is no upcoming split for Myriad Genetics.

Q

What sector and industry does Myriad Genetics (MYGN) operate in?

A

Myriad Genetics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved